phagos

Phagos Biotech is a biotechnology startup founded in 2021 with the mission to address the urgent global challenge of antibiotic resistance. Their slogan "Unleash Bacteriophage Potential" reflects their dedication to harnessing the natural predator of bacteria, the bacteriophage, as a solution for life-threatening infectious diseases. Recognizing antibiotic resistance as a top 10 threat to humanity, Phagos is committed to leveraging entrepreneurship for positive change in the field of healthcare. Their approach is not only innovative but also sustainable, aiming to provide an alternative to antibiotics with the potential to revolutionize the industry. The recent €1.35M grant investment received by Phagos on 18 August 2023 from Bpifrance indicates a strong endorsement of their groundbreaking work. With the headquarter in France, Phagos Biotech is positioned at the forefront of the biotechnology industry, offering investors an opportunity to support a disruptive solution to a pressing global health concern. As they invite others to embark on the journey to Unleash Bacteriophage Potential, Phagos Biotech presents a compelling vision for the future of healthcare and biotechnology.